African and Asia Avian Flu Market to 2032

Overview

The African and Asia Avian Flu Market is expected to reach a 518.27 USD Million by 2032 and is projected to grow at a CAGR of 7.96% from 2025 to 2032.

Revenue, 2024 (USD Million)
280.83
Forecast, 2032 (USD Million)
518.27
CAGR, 2024 - 2032
7.96%
Report Coverage
Asia-Pacific

African and Asia Avian Flu Market 2018-2032 USD Million

African and Asia Avian Flu Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 280.83 USD Million
  • Projected Market Size (2032): 518.27 USD Million
  • CAGR (2025-2032): 7.96%

Key Findings of African and Asia Avian Flu Market

  • The African and Asia Avian Flu Market was valued at 518.27 USD Million in 2024.
  • The African and Asia Avian Flu Market is likely to grow at a CAGR of 7.96% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Veterinary in Application Segment accounted for the largest share of the market with a revenue of 255.87 USD Million
  • The fastest growing segment Gallimune/ Gallivac/ Volvac in Vaccine Segment grew Fastest with a CAGR of 8.74% during the forecast period from 2024 to 2032.

African and Asia Avian Flu Market Scope

African and Asia Avian Flu Market Segmentation & Scope
Strain
  • H7 Strain
  • H9 Strain
  • H5 Strain
Type
  • Low Pathogenic Avian Influenza (LPAI)
  • Highly Pathogenic Avian Influenza (HPAI)
Vaccine
  • Gallimune/ Gallivac/ Volvac
  • Mefluvac
  • Viraflu
  • Others
Vaccine Category
  • Live Recombinant Vaccines
  • Combination Vaccines
  • DNA vaccine
  • Inactivated Vaccines
Application
  • Veterinary
  • Human
End User
  • Poultry Farms
  • Veterinary Clinics
  • Governmental Organizations
  • Research Institutes
  • Others
Distribution Channel
  • Direct Tenders
  • Third Party Distributor
  • Retail Sales

African and Asia Avian Flu Market Data Coverage Insights

Study Period 2024-2032
Base Year 2023
Unit Revenue in USD Million
Market Value in 2024 280.83 USD Million
Market Value in 2032 518.27 USD Million
CAGR (2025-2032) 7.96%
Historic Data 2016-2023
Market Segments Covered Strain,Type,Vaccine,Vaccine Category,Application,End User,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 280.83 USD Million in 2024
    • Key Country: China, leading in terms of revenue with value of 46.93 USD Million in 2024.

Segments and Scope

  • African and Asia Avian Flu Market to 2032, By Strain
    • H5 Strain is the largest segment in African and Asia Avian Flu Market to 2032 with a revenue of 115.61 USD Million in the year 2024.
    • H5 Strain is the Fastest growing segment in African and Asia Avian Flu Market to 2032 with a Growth rate of 8.22 % in forecast period 2025-2032.
  • African and Asia Avian Flu Market to 2032, By Type
    • Low Pathogenic Avian Influenza (LPAI) is the largest segment in African and Asia Avian Flu Market to 2032 with a revenue of 160.61 USD Million in the year 2024.
    • Highly Pathogenic Avian Influenza (HPAI) is the Fastest growing segment in African and Asia Avian Flu Market to 2032 with a Growth rate of 7.72 % in forecast period 2025-2032.
  • African and Asia Avian Flu Market to 2032, By Vaccine
    • Gallimune/ Gallivac/ Volvac is the largest segment in African and Asia Avian Flu Market to 2032 with a revenue of 123.93 USD Million in the year 2024.
    • Gallimune/ Gallivac/ Volvac is the Fastest growing segment in African and Asia Avian Flu Market to 2032 with a Growth rate of 8.74 % in forecast period 2025-2032.
  • African and Asia Avian Flu Market to 2032, By Vaccine Category
    • Inactivated Vaccines is the largest segment in African and Asia Avian Flu Market to 2032 with a revenue of 184.64 USD Million in the year 2024.
    • Live Recombinant Vaccines is the Fastest growing segment in African and Asia Avian Flu Market to 2032 with a Growth rate of 7.93 % in forecast period 2025-2032.
  • African and Asia Avian Flu Market to 2032, By Application
    • Veterinary is the largest segment in African and Asia Avian Flu Market to 2032 with a revenue of 255.87 USD Million in the year 2024.
    • Veterinary is the Fastest growing segment in African and Asia Avian Flu Market to 2032 with a Growth rate of 7.98 % in forecast period 2025-2032.
  • African and Asia Avian Flu Market to 2032, By End User
    • Poultry Farms is the largest segment in African and Asia Avian Flu Market to 2032 with a revenue of 156.95 USD Million in the year 2024.
    • Veterinary Clinics is the Fastest growing segment in African and Asia Avian Flu Market to 2032 with a Growth rate of 7.69 % in forecast period 2025-2032.
  • African and Asia Avian Flu Market to 2032, By Distribution Channel
    • Direct Tenders is the largest segment in African and Asia Avian Flu Market to 2032 with a revenue of 128.07 USD Million in the year 2024.
    • Third Party Distributor is the Fastest growing segment in African and Asia Avian Flu Market to 2032 with a Growth rate of 7.58 % in forecast period 2025-2032.

African and Asia Avian Flu Market Company Share Analysis

 
African and Asia Avian Flu Market Company Share Analysis
African and Asia Avian Flu Market Company Share Analysis

African and Asia Avian Flu Market Geographical Sales Distribution, 2018-2032 USD Million

African and Asia Avian Flu Market Geographical Sales Distribution, 2018-2032 USD Million

African and Asia Avian Flu Market Company Profiling

African and Asia Avian Flu Market Company Profiling
Frequently Asked Questions
The African and Asia Avian Flu Market is segmented based on Segmentation Strain,Type,Vaccine,Vaccine Category,Application,End User,Distribution Channel.
African and Asia Avian Flu Market was valued at USD 280.83(Revenue in USD Million) in 2023.
African and Asia Avian Flu Market is projected to grow at a CAGR of 7.96% during the forecast period of 2024 to 2032.
The Veterinary segment is expected to dominate the African and Asia Avian Flu Market, holding a largest market share of 255.87 USD Million in 2024

Coming Soon....

African and Asia Avian Flu Market Scope

African and Asia Avian Flu Market Segmentation & Scope
Strain
  • H7 Strain
  • H9 Strain
  • H5 Strain
Type
  • Low Pathogenic Avian Influenza (LPAI)
  • Highly Pathogenic Avian Influenza (HPAI)
Vaccine
  • Gallimune/ Gallivac/ Volvac
  • Mefluvac
  • Viraflu
  • Others
Vaccine Category
  • Live Recombinant Vaccines
  • Combination Vaccines
  • DNA vaccine
  • Inactivated Vaccines
Application
  • Veterinary
  • Human
End User
  • Poultry Farms
  • Veterinary Clinics
  • Governmental Organizations
  • Research Institutes
  • Others
Distribution Channel
  • Direct Tenders
  • Third Party Distributor
  • Retail Sales
Frequently Asked Questions
The African and Asia Avian Flu Market is segmented based on Segmentation Strain,Type,Vaccine,Vaccine Category,Application,End User,Distribution Channel.
African and Asia Avian Flu Market was valued at USD 280.83(Revenue in USD Million) in 2023.
African and Asia Avian Flu Market is projected to grow at a CAGR of 7.96% during the forecast period of 2024 to 2032.
The estimated market value of the African and Asia Avian Flu Market for final year is USD 518.27 (USD Million).

African and Asia Avian Flu Market Company Profiling

African and Asia Avian Flu Market Company Profiling
Frequently Asked Questions
The African and Asia Avian Flu Market is segmented based on Segmentation Strain,Type,Vaccine,Vaccine Category,Application,End User,Distribution Channel.
African and Asia Avian Flu Market was valued at USD 280.83(Revenue in USD Million) in 2023.
African and Asia Avian Flu Market is projected to grow at a CAGR of 7.96% during the forecast period of 2024 to 2032.
The estimated market value of the African and Asia Avian Flu Market for final year is USD 518.27 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.